Enrolling Rheumatoid Arthritis Studies

Below are our currently enrolling studies for patients with rheumatoid arthritis.

Sponsor: Crescendo Bioscience

Protocol Number: 133-CL-01 

In this 12-month multi-center prospective, site-randomized, two-arm trial, approximately 318 biologic-naïve subjects with RA who are candidates for treatment intensification due to inadequate response to MTX monotherapy will be enrolled at up to 60 study sites.

Detailed Information:

Here

To learn more or see if you qualify:

Click Here

Detailed Information:

Here

To learn more or see if you qualify:

Click Here

Detailed Information:

Here

To learn more or see if you qualify:

Click Here